---
{"dg-publish":true,"permalink":"/USMLE/Cardiology/Beta blockers/"}
---

# β1
- Heart
- <span style="background:rgba(240, 200, 0, 0.2)">Kidneys</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">β1 blockade of the juxtaglomerular cells → ↓ renin release → ↓ angiotensin II conversion → ↓ H<sub>2</sub>O resorption → ↓ BP</span>

>[!tip] 
>- Beta-1 agonists can result in increased renin release → [[USMLE/Cardiology/Hypokalemia\|hypokalemia]]
>- [[USMLE/Pharmacology/Beta-2 adrenergic agonists\|Beta-2 agonists]] can increase the activity of the Na-K-ATPase pump → [[USMLE/Cardiology/Hypokalemia\|hypokalemia]] (transient)
# Beta blocker overdose
## Clinical features
- Clinical features of CV drug poisoning: typically <span style="background:rgba(240, 200, 0, 0.2)">bradycardia, hypotension, and CNS depression</span>
- Other features
	- [[USMLE/Psychiatry/Delirium\|Delirium]]
	- Respiratory depression
	- [[USMLE/Neurology/Seizures and epilepsy\|Seizures]] (typically seen with propranolol) 
	- Bronchospasm (rare)
## Management
- Hypotension: IV fluid bolus
- Symptomatic bradycardia: atropine
- <span style="background:rgba(240, 200, 0, 0.2)">High-dose glucagon therapy</span>
	- Glucagon activates adenylate cyclase, leading to increased intracellular cAMP during depolarization, which improves cardiac contractility and heart rate.
